NCT04493385Recruiting
The Hepatitis C Transplant Collaborative
Nationwide Hepatitis C NAT+ Cardiac Transplant Experience
Source: ClinicalTrials.gov · Last updated 22 Jan 2026
Brief summary (registry, in English)
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 13 Jul 2020
- Start date
- 16 Sept 2019
- Primary completion date
- Dec 2030
- Lead sponsor
- Baylor Research Institute
- NCT number
- NCT04493385
What you commit to
- Study type: Observational
- Planned participants: 500
- From 16 Sept 2019 to the primary completion date, Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 1\. Multi-organ transplantation
Who the study is looking for
- Recipient of a proven HCV NAT+ donor heart.
- Re-transplant patients will be included.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Baylor Scott & White health research institute Coordinator of this site? Confirm its status | Dallas | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.